Personalis, Inc. (PSNL)
17.07
+0.27
(+1.61%)
USD |
NASDAQ |
Aug 28, 16:00
17.08
+0.01
(+0.06%)
After-Hours: 20:00
Personalis Cash from Operations (Quarterly) : -25.77M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.77M |
| March 31, 2026 | -22.48M |
| December 31, 2025 | -22.25M |
| September 30, 2025 | -21.80M |
| June 30, 2025 | -12.94M |
| March 31, 2025 | -17.96M |
| December 31, 2024 | -7.796M |
| September 30, 2024 | -6.198M |
| June 30, 2024 | -10.74M |
| March 31, 2024 | -20.41M |
| December 31, 2023 | -13.42M |
| September 30, 2023 | -16.68M |
| June 30, 2023 | -10.41M |
| March 31, 2023 | -15.74M |
| December 31, 2022 | -16.76M |
| September 30, 2022 | -14.76M |
| June 30, 2022 | -27.35M |
| Date | Value |
|---|---|
| March 31, 2022 | -11.36M |
| December 31, 2021 | -15.27M |
| September 30, 2021 | -17.88M |
| June 30, 2021 | -25.93M |
| March 31, 2021 | -11.74M |
| December 31, 2020 | -2.532M |
| September 30, 2020 | -16.12M |
| June 30, 2020 | -15.35M |
| March 31, 2020 | -8.643M |
| December 31, 2019 | 2.405M |
| September 30, 2019 | -9.638M |
| June 30, 2019 | -10.90M |
| March 31, 2019 | 0.066M |
| December 31, 2018 | 3.203M |
| September 30, 2018 | -0.431M |
| June 30, 2018 | 2.077M |
| March 31, 2018 | 0.723M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tempus AI, Inc. | -8.05M |
| 10X Genomics, Inc. | 16.97M |
| Alamar Biosciences, Inc. (California) | -11.32M |
| Adaptive Biotechnologies Corp. | -6.40M |
| Champions Oncology, Inc. | -1.998M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 38.16M |
| Cash from Financing (Quarterly) | 7.988M |
| Free Cash Flow | -100.98M |
| Free Cash Flow Per Share (Quarterly) | -0.2803 |
| Free Cash Flow to Equity (Quarterly) | -28.77M |
| Free Cash Flow to Firm (Quarterly) | -29.52M |
| Free Cash Flow Yield | -6.06% |